| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Revenue | $5.22B | +19.7% |
| Cost of Revenue | $894.9M | +11.4% |
| Gross Profit | $4.32B | +21.5% |
| R&D Expense | $2.67B | +22.2% |
| SG&A Expense | $647.0M | +6.0% |
| Operating Income | -$130.4M | -11.4% |
| Pre-tax Income | -$98.9M | -15.8% |
| Income Tax | $157.8M | -26.6% |
| Net Income | -$256.7M |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.51B | +15.4% |
| Short-term Investments | $424.3M | +161.9% |
| Accounts Receivable | $778.3M | +23.9% |
| Current Assets | $3.89B | +26.5% |
| Total Assets | $6.04B | +15.9% |
| Current Liabilities | $3.18B | +21.9% |
| Long-term Debt | $987.7M | +0.2% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.46B | +0.8% |
| Capital Expenditures | $44.9M | +37.7% |
| Investing Cash Flow | -$342.3M | +64.5% |
| Financing Cash Flow | -$782.6M | -91.7% |
| Free Cash Flow | $1.42B | -0.0% |
| +14.6% |
| EPS (Basic) | -$0.98 | +15.5% |
| EPS (Diluted) | -$0.98 | +15.5% |
| Total Liabilities |
| $4.70B |
| +12.4% |
| Stockholders' Equity | $1.35B | +30.3% |